Driven by purpose, guided by science, committed to transforming lives through early detection and intervention.
We believe that early detection is the key to changing the trajectory of neurodegenerative diseases. Our team of world-class researchers and clinicians is dedicated to developing accessible, accurate diagnostic tools that can identify these conditions years before symptoms appear.
By enabling early intervention, we aim to preserve cognitive function, improve quality of life, and ultimately reduce the global burden of dementia on families and healthcare systems.
By 2030, we aim to enable early detection of neurodegenerative diseases in over 1 million individuals worldwide, potentially preventing or delaying the onset of dementia symptoms and improving quality of life for patients and their families.
